David S. Arrington

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

David S.
Arrington worked as VP-Investor Relations & Corporate Communications at Achaogen, Inc. from 2017 to 2018.
He also worked as VP-Investor Relations & Corporate Affairs at Coherus BioSciences, Inc. and as VP-Investor Relations & Corporate Communications at Freeline Therapeutics Holdings Plc.
Arrington received his undergraduate degree from Washington State University.

Precedenti posizioni note di David S. Arrington

Società	Posizione	Fine
ACHAOGEN	Contatto Relazioni con gli Investitori	01/04/2018
FREELINE THERAPEUTICS HOLDINGS PLC	Contatto Relazioni con gli Investitori	-
COHERUS BIOSCIENCES, INC.	Contatto Relazioni con gli Investitori	-

Vedi nel dettaglio l'esperienza di David S. Arrington

Formazione di David S. Arrington

Washington State University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David S. Arrington

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
COHERUS BIOSCIENCES, INC.	Health Technology

Aziende private	2
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.	Health Technology